Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
anti-mPD1 mimotope IgG
- Development stage
- Preclinical
- Lead developer
- Medical University of Vienna
- Modality
- Antibody-Based Therapeutics
- Administration
- Parenteral
01
Overview
Anti-mPD1 mimotope IgG is a preclinical rabbit-derived polyclonal antibody generated by immunizing rabbits with a B-cell mimotope of mouse programmed cell death protein 1 (mPD-1). Developed by the Medical University of Vienna in collaboration with Imugene, this antibody was designed as a proof-of-concept therapeutic to evaluate the in vivo anti-tumor efficacy of active immunization targeting PD-1. In preclinical studies, anti-mPD1 mimotope IgG successfully blocked the interaction between mPD-1 and its ligand mPD-L1, leading to significant tumor growth reduction in syngeneic mouse models of HER2-positive breast cancer.
- Other names
- anti-mPD-1 mimotope IgGanti-mPD1 mimotope IgGanti-mPD 1 mimotope IgGanti-mPD1 mimotope antibodyanti-mPD-1 mimotope antibodyanti-mPD 1 mimotope antibodyanti-mouse PD-1 mimotope IgG
02
Targets
PDCD1 (Programmed cell death protein 1 receptor)
Beyond the preview
Go deeper on anti-mPD1 mimotope IgG.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on anti-mPD1 mimotope IgG.